Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Atrion's cash to debt ratio for the quarter that ended in Dec. 2023 was No Debt (1).
If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Atrion could pay off its debt using the cash in hand for the quarter that ended in Dec. 2023.
(1) Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
The historical rank and industry rank for Atrion's Cash-to-Debt or its related term are showing as below:
ATRI'
s Cash-to-Debt Range Over the Past 10 Years
Min: 1.39 Med: No Debt Max: No Debt
Current: 1.39
During the past 13 years, Atrion's highest Cash to Debt Ratio was No Debt. The lowest was 1.39. And the median was No Debt.
Atrion Cash-to-Debt Historical Data
The historical data trend for Atrion's Cash-to-Debt can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
|
Atrion Annual Data
|
|
Trend |
Dec14 |
Dec15 |
Dec16 |
Dec17 |
Dec18 |
Dec19 |
Dec20 |
Dec21 |
Dec22 |
Dec23 |
| Cash-to-Debt |
|
|
|
|
|
|
No Debt |
No Debt |
No Debt |
No Debt |
No Debt |
|
Atrion Quarterly Data
|
|
Mar19 |
Jun19 |
Sep19 |
Dec19 |
Mar20 |
Jun20 |
Sep20 |
Dec20 |
Mar21 |
Jun21 |
Sep21 |
Dec21 |
Mar22 |
Jun22 |
Sep22 |
Dec22 |
Mar23 |
Jun23 |
Sep23 |
Dec23 |
| Cash-to-Debt |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
No Debt |
No Debt |
1.42 |
1.00 |
No Debt |
Competitive Comparison
For the Medical Instruments & Supplies subindustry, Atrion's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Atrion Cash-to-Debt Distribution
For the Medical Devices & Instruments industry and Healthcare sector, Atrion's Cash-to-Debt distribution charts can be found below:
* The bar in red indicates where Atrion's Cash-to-Debt falls into.
Atrion Cash-to-Debt Calculation
This is the ratio of a company's
Cash, Cash Equivalents, Marketable Securities
to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.
Atrion's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:
Atrion had no debt (1).
Atrion's Cash to Debt Ratio for the quarter that ended in Dec. 2023 is calculated as:
Atrion had no debt (1).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Atrion (Atrion) Business Description
Traded in Other Exchanges
N/A
Address
One Allentown Parkway, Allen, TX, USA, 75002-4211
Atrion Corp develops and manufactures products for medical applications. Its fluid-delivery products contribute the largest proportion of revenue and include valves that can hold and release controlled amounts of fluids or gases and are often used in anesthesia and oncology applications. Atrion's cardiovascular products include the MPS2 Myocardial Protection System, which delivers fluids and medications, mixes drugs, and controls temperature and pressure during open-heart surgery. The cardiovascular business also sells cardiac-surgery vacuum relief valves, inflation devices, and other products used in heart surgery. The firm's ophthalmic products include medical devices that disinfect contact lenses. Atrion generates the majority of revenue in the United States.
Executives
| Preston G Athey |
director |
ONE ALLENTOWN PKWY, ALLEN TX 75002 |
| David A Battat |
officer: President & CEO |
2700 HALKEY-ROBERTS PLACE NORTH, ST. PETERSBURG FL 33716-4103 |
| Jeannette Bankes |
director |
ONE ALLENTOWN PARKWAY, ONE ALLENTOWN PARKWAY, ALLEN TX 75002 |
| Morgan Hugh J Jr |
director |
|
| Ronald Nicholas Spaulding |
director |
ONE ALLENTOWN PARKWAY, ALLEN TX 75002 |
| Cindy Ferguson |
officer: Officer/ CFO |
ONE ALLENTOWN PARKWAY, ALLEN TX 75002 |
| Jeffery Strickland |
officer: Vice President & CFO |
|
| Emile A Battat |
director, officer: Chairman |
ONE ALLENTOWN PARKWAY, ALLEN TX 75002 |
| Maria Sainz |
director |
C/O ORTHOFIX INTERNATIONAL N. V., 3451 PLANO PARKWAY, LEWISVILLE TX 75056 |
| Stupp John P Jr |
director |
STUPP JOHN P JR, #18 ST. ANDREWS DR., ST LOUIS MO 63124 |
| Roger F Stebbing |
director |
|
| Ronald N Spaulding |
director |
C/O GUIDANT CORP, 111 MONUMENT CIRCLE #2900, INDIANAPOLIS IN 46204-5129 |
| Richard O Jacobson |
director |
ONE ALLENTOWN PARKWAY, C/O ATRION, ALLEN TX 75002 |
| Maley John H P |
director |
6 ROCK CREST LANE, SIGNAL MOUNTAIN TN 37377 |
| Margaret Maxwell Zagel |
director |
C/O TELLABS OPERATIONS INC, 4951 INDIANA AVE, LISLE IL 60532 |
Atrion (Atrion) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ATRI has been successfully added to your